U.S. Department of Health & Human Services
Open Funding Opportunities
| FOA # | FOA Title | Research Focus Area | Earliest Submission Date | Expiration Date | Posted Date Sort ascending |
|---|---|---|---|---|---|
| RFA-NS-21-029 | HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sat, 06/19/2021 | Wed, 10/11/2023 | Tue, 06/08/2021 |
|
no summary
|
|||||
| NOT-NS-21-026 | HEAL Initiative: Notice of Special Interest (NOSI): Limited Competition to Support Mentorship of Junior Investigators | Sat, 06/12/2021 | Sun, 06/13/2021 | Fri, 04/09/2021 | |
|
no summary
|
|||||
| RFA-NS-21-015 | HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sat, 03/27/2021 | Wed, 10/11/2023 | Thu, 03/11/2021 |
|
no summary
|
|||||
| OTA-21-005 | HEAL Initiative: EPPIC-Net Pain Research Asset Application (OT1) | Clinical Research in Pain Management | Tue, 09/03/2019 | Tue, 09/03/2024 | Thu, 02/25/2021 |
|
no summary
|
|||||
| NOT-NS-20-107 | Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | Sun, 11/15/2020 | Thu, 05/16/2024 | Mon, 10/19/2020 | |
|
no summary
|
|||||
| RFA-NS-21-010 | HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) | Preclinical and Translational Research in Pain Management | Sun, 10/18/2020 | Thu, 09/08/2022 | Wed, 09/16/2020 |
|
no summary
|
|||||
| PAR-20-092 | Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) | Fri, 01/24/2020 | Fri, 09/02/2022 | Fri, 01/24/2020 | |
|
no summary
|
|||||
| RFA-NS-20-008 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-011 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-010 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-009 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Thu, 10/03/2019 |
|
no summary
|
|||||
| RFA-DA-19-019 | HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional) | New Strategies to Prevent and Treat Opioid Addiction | Sun, 12/09/2018 | Thu, 09/09/2021 | Wed, 09/25/2019 |
|
no summary
|
|||||
| RFA-DA-19-020 | HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional) | Mon, 12/10/2018 | Thu, 09/09/2021 | Wed, 09/25/2019 | |
|
no summary
|
|||||